TY - JOUR
T1 - Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease
AU - Dey, Madhurima
AU - Gunn-Moore, Frank J.
AU - Platt, Bettina
AU - Smith, Terry K.
N1 - Authors thank the Alzheimer’s Society Scottish Doctoral Training Centre and the RS Macdonald Trust Transition Fund for funding the research presented.
PY - 2020/8/31
Y1 - 2020/8/31
N2 - BackgroundLipid
dysregulation is associated with several key characteristics of
Alzheimer’s disease (AD), including amyloid-β and tau neuropathology,
neurodegeneration, glucose hypometabolism, as well as synaptic and
mitochondrial dysfunction. The β-site amyloid precursor protein cleavage
enzyme 1 (BACE1) is associated with increased amyloidogenesis, and has
been affiliated with diabetes via its role in metabolic regulation.MethodsThe
research presented herein investigates the role of hBACE1 in lipid
metabolism and whether specific brain regions show increased
vulnerability to lipid dysregulation. By utilising advanced mass
spectrometry techniques, a comprehensive, quantitative lipidomics
analysis was performed to investigate the phospholipid, sterol, and
fatty acid profiles of the brain from the well-known PLB4 hBACE1
knock-in mouse model of AD, which also shows a diabetic phenotype, to
provide insight into regional alterations in lipid metabolism.ResultsResults
show extensive region – specific lipid alterations in the PLB4 brain
compared to the wild-type, with decreases in the
phosphatidylethanolamine content of the cortex and triacylglycerol
content of the hippocampus and hypothalamus, but increases in the
phosphatidylcholine, phosphatidylinositol, and diacylglycerol content of
the hippocampus. Several sterol and fatty acids were also specifically
decreased in the PLB4 hippocampus.ConclusionCollectively,
the lipid alterations observed in the PLB4 hBACE1 knock-in AD mouse
model highlights the regional vulnerability of the brain, in particular
the hippocampus and hypothalamus, to lipid dysregulation, hence supports
the premise that metabolic abnormalities have a central role in both AD
and diabetes.
AB - BackgroundLipid
dysregulation is associated with several key characteristics of
Alzheimer’s disease (AD), including amyloid-β and tau neuropathology,
neurodegeneration, glucose hypometabolism, as well as synaptic and
mitochondrial dysfunction. The β-site amyloid precursor protein cleavage
enzyme 1 (BACE1) is associated with increased amyloidogenesis, and has
been affiliated with diabetes via its role in metabolic regulation.MethodsThe
research presented herein investigates the role of hBACE1 in lipid
metabolism and whether specific brain regions show increased
vulnerability to lipid dysregulation. By utilising advanced mass
spectrometry techniques, a comprehensive, quantitative lipidomics
analysis was performed to investigate the phospholipid, sterol, and
fatty acid profiles of the brain from the well-known PLB4 hBACE1
knock-in mouse model of AD, which also shows a diabetic phenotype, to
provide insight into regional alterations in lipid metabolism.ResultsResults
show extensive region – specific lipid alterations in the PLB4 brain
compared to the wild-type, with decreases in the
phosphatidylethanolamine content of the cortex and triacylglycerol
content of the hippocampus and hypothalamus, but increases in the
phosphatidylcholine, phosphatidylinositol, and diacylglycerol content of
the hippocampus. Several sterol and fatty acids were also specifically
decreased in the PLB4 hippocampus.ConclusionCollectively,
the lipid alterations observed in the PLB4 hBACE1 knock-in AD mouse
model highlights the regional vulnerability of the brain, in particular
the hippocampus and hypothalamus, to lipid dysregulation, hence supports
the premise that metabolic abnormalities have a central role in both AD
and diabetes.
KW - PLB4
KW - Quantitative lipidomics
KW - Brain regions
U2 - 10.1186/s12944-020-01367-8
DO - 10.1186/s12944-020-01367-8
M3 - Article
SN - 1476-511X
VL - 19
JO - Lipids in Health and Disease
JF - Lipids in Health and Disease
M1 - 201
ER -